Come up with a name for your new list and we'll add to it:
Inhibikase Therapeutics raised a round of funding on April 06, 2009. Investors include
Five Ventures Business Plan Competition.
Inhibikase Therapeutics is a class of drug that is simultaneously effective against bacterial and viral infections in humans.…